204 related articles for article (PubMed ID: 8196662)
21. Initiator elements and regulated expression of the herpes simplex virus thymidine kinase gene.
Cook WJ; Lin SM; DeLuca NA; Coen DM
J Virol; 1995 Nov; 69(11):7291-4. PubMed ID: 7474156
[TBL] [Abstract][Full Text] [Related]
22. Developmental acquisition of enhancer function requires a unique coactivator activity.
Majumder S; Zhao Z; Kaneko K; DePamphilis ML
EMBO J; 1997 Apr; 16(7):1721-31. PubMed ID: 9130716
[TBL] [Abstract][Full Text] [Related]
23. cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo.
Soares K; Hwang DY; Ramakrishnan R; Schmidt MC; Fink DJ; Glorioso JC
J Virol; 1996 Aug; 70(8):5384-94. PubMed ID: 8764049
[TBL] [Abstract][Full Text] [Related]
24. Regulation of herpes simplex virus true late gene expression: sequences downstream from the US11 TATA box inhibit expression from an unreplicated template.
Kibler PK; Duncan J; Keith BD; Hupel T; Smiley JR
J Virol; 1991 Dec; 65(12):6749-60. PubMed ID: 1658372
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation by varicella-zoster virus (VZV) and herpes simplex virus type-1 trans-activating genes.
Inchauspe G; Ostrove JM
Virology; 1989 Dec; 173(2):710-4. PubMed ID: 2556849
[TBL] [Abstract][Full Text] [Related]
26. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.
Ray A; LaForge KS; Sehgal PB
Mol Cell Biol; 1990 Nov; 10(11):5736-46. PubMed ID: 2233715
[TBL] [Abstract][Full Text] [Related]
27. Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators.
Kamine J; Subramanian T; Chinnadurai G
J Virol; 1993 Nov; 67(11):6828-34. PubMed ID: 8411386
[TBL] [Abstract][Full Text] [Related]
28. Characterization of eukaryotic transcriptional control signals by assay of herpes simplex virus type 1 thymidine kinase.
Lang JC; Wilkie NM; Spandidos DA
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2679-96. PubMed ID: 6319553
[TBL] [Abstract][Full Text] [Related]
29. The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities.
Chavrier P; Gruffat H; Chevallier-Greco A; Buisson M; Sergeant A
J Virol; 1989 Feb; 63(2):607-14. PubMed ID: 2536096
[TBL] [Abstract][Full Text] [Related]
30. The erythroid-specific protein cGATA-1 mediates distal enhancer activity through a specialized beta-globin TATA box.
Fong TC; Emerson BM
Genes Dev; 1992 Apr; 6(4):521-32. PubMed ID: 1559609
[TBL] [Abstract][Full Text] [Related]
31. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
[TBL] [Abstract][Full Text] [Related]
32. Sp1 and NF-Y are necessary and sufficient for growth-dependent regulation of the hamster thymidine kinase promoter.
Sorensen P; Wintersberger E
J Biol Chem; 1999 Oct; 274(43):30943-9. PubMed ID: 10521489
[TBL] [Abstract][Full Text] [Related]
33. Examination of the roles of transcription factor Sp1-binding sites and an octamer motif in trans induction of the herpes simplex virus thymidine kinase gene.
Böni J; Coen DM
J Virol; 1989 Sep; 63(9):4088-92. PubMed ID: 2548017
[TBL] [Abstract][Full Text] [Related]
34. The herpes simplex virus thymidine kinase gene promoter contains a novel thyroid hormone response element.
Park HY; Davidson D; Raaka BM; Samuels HH
Mol Endocrinol; 1993 Mar; 7(3):319-30. PubMed ID: 8387156
[TBL] [Abstract][Full Text] [Related]
35. Effect of in vitro mutations in a vaccinia virus early promoter region monitored by herpes simplex virus thymidine kinase expression in recombinant vaccinia virus.
Coupar BE; Boyle DB; Both GW
J Gen Virol; 1987 Sep; 68 ( Pt 9)():2299-309. PubMed ID: 2821171
[TBL] [Abstract][Full Text] [Related]
36. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression.
Finkenzeller G; Sparacio A; Technau A; Marmé D; Siemeister G
Oncogene; 1997 Aug; 15(6):669-76. PubMed ID: 9264407
[TBL] [Abstract][Full Text] [Related]
37. Transfection with the isolated herpes simplex virus thymidine kinase genes. I. Minimal size of the active fragments from HSV-1 and HSV-2.
Reyes GR; Jeang KT; Hayward GS
J Gen Virol; 1982 Oct; 62 (Pt 2)():191-206. PubMed ID: 6292348
[TBL] [Abstract][Full Text] [Related]
38. Repression of the alpha0 gene by ICP4 during a productive herpes simplex virus infection.
Lium EK; Panagiotidis CA; Wen X; Silverstein S
J Virol; 1996 Jun; 70(6):3488-96. PubMed ID: 8648681
[TBL] [Abstract][Full Text] [Related]
39. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.
Dostatni N; Lambert PF; Sousa R; Ham J; Howley PM; Yaniv M
Genes Dev; 1991 Sep; 5(9):1657-71. PubMed ID: 1653173
[TBL] [Abstract][Full Text] [Related]
40. Interaction of bovine herpesvirus 4 (BHV-4) immediate early 2 gene product with BHV-4 thymidine kinase promoter-regulatory region.
Zhang L; van Santen VL
J Gen Virol; 1995 Oct; 76 ( Pt 10)():2433-45. PubMed ID: 7595347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
